Elizabeth Yang

713 total citations
33 papers, 495 citations indexed

About

Elizabeth Yang is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Elizabeth Yang has authored 33 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Elizabeth Yang's work include Hemoglobinopathies and Related Disorders (17 papers), Iron Metabolism and Disorders (15 papers) and Blood groups and transfusion (7 papers). Elizabeth Yang is often cited by papers focused on Hemoglobinopathies and Related Disorders (17 papers), Iron Metabolism and Disorders (15 papers) and Blood groups and transfusion (7 papers). Elizabeth Yang collaborates with scholars based in United States, Sweden and Italy. Elizabeth Yang's co-authors include Ravi Veeraswamy, William G. Nelson, Angelo M. De Marzo, Valérie Marchi, Xiaohui Lin, E C Friedberg, Peter H. Domer, David R. Head, Susana C. Raimondi and Michael J. Eckrich and has published in prestigious journals such as Blood, Molecular and Cellular Biology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Elizabeth Yang

29 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Yang United States 11 294 149 128 68 51 33 495
Emily K. Thomas United States 11 281 1.0× 104 0.7× 40 0.3× 33 0.5× 23 0.5× 20 527
Gisela Sanchez‐Williams United States 8 261 0.9× 279 1.9× 80 0.6× 39 0.6× 52 1.0× 8 601
Emanuela Messa Italy 11 277 0.9× 456 3.1× 275 2.1× 22 0.3× 22 0.4× 35 629
Ilaria Defilippi Italy 9 215 0.7× 312 2.1× 197 1.5× 14 0.2× 35 0.7× 21 501
Kalliopi N. Manola Greece 12 238 0.8× 215 1.4× 76 0.6× 28 0.4× 8 0.2× 42 459
Sara Santos Franco United Kingdom 8 154 0.5× 73 0.5× 113 0.9× 31 0.5× 101 2.0× 10 380
F. Messa Italy 8 366 1.2× 453 3.0× 208 1.6× 43 0.6× 21 0.4× 15 724
V. Picard France 9 107 0.4× 248 1.7× 111 0.9× 47 0.7× 119 2.3× 11 420
Aneta Bałabas Poland 12 152 0.5× 80 0.5× 32 0.3× 24 0.4× 48 0.9× 36 403
Christian Scharenberg Sweden 6 191 0.6× 239 1.6× 175 1.4× 46 0.7× 10 0.2× 9 487

Countries citing papers authored by Elizabeth Yang

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Yang more than expected).

Fields of papers citing papers by Elizabeth Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Yang. The network helps show where Elizabeth Yang may publish in the future.

Co-authorship network of co-authors of Elizabeth Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Yang. A scholar is included among the top collaborators of Elizabeth Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Yang. Elizabeth Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Elizabeth, et al.. (2025). Virtual vitreoretinal clinics: a service delivery pathway of the future. International Journal of Retina and Vitreous. 11(1). 61–61.
2.
Larkin, Sandra, et al.. (2023). Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot study. Pediatric Blood & Cancer. 70(8). e30423–e30423. 5 indexed citations
3.
Lewis, Angela, et al.. (2023). High hydroxyurea usage in sickle cell anemia regardless of patient demographics. Pediatric Blood & Cancer. 71(2). e30728–e30728.
5.
Gatenby, J. Christopher, Elizabeth Yang, Adetola A. Kassim, et al.. (2021). Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity. Cardiovascular Engineering and Technology. 13(1). 104–119. 1 indexed citations
6.
Larkin, Sandra, et al.. (2021). The Effect of Voxelotor on Exercise Capacity of Youths with Sickle Cell Anemia. Blood. 138(Supplement 1). 2045–2045. 2 indexed citations
7.
Smith, Wally R., Donna K. McClish, Richard Lottenberg, et al.. (2019). The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study. Blood. 134(Supplement_1). 2309–2309. 1 indexed citations
8.
Smith, Wally R., Donna K. McClish, Shirley Johnson, et al.. (2019). The Effect of Patient Navigators on Health-Related Quality of Life in Sickle Cell Anemia: The SHIP-HU Study. Blood. 134(Supplement_1). 2168–2168. 1 indexed citations
9.
Du, Xing, Xufeng Fu, Kun Yao, et al.. (2017). Bcl-2 delays cell cycle through mitochondrial ATP and ROS. Cell Cycle. 16(7). 707–713. 34 indexed citations
10.
Yang, Elizabeth, et al.. (2017). Hemoglobin C trait accentuates erythrocyte dehydration in hereditary xerocytosis. Pediatric Blood & Cancer. 64(8). 11 indexed citations
11.
Lewis, Angela, et al.. (2016). Discontinuation of Folic Acid Supplementation in Young Patients With Sickle Cell Anemia. Journal of Pediatric Hematology/Oncology. 39(6). 470–472. 6 indexed citations
12.
Heeney, Matthew M., Patricia Adams‐Graves, Elizabeth Yang, et al.. (2014). Comparison of Clinical Outcomes Between Adult and Pediatric Patients (pts) with Sickle Cell Disease (SCD): 3-Year (y) Follow-up in a Prospective, Longitudinal, Noninterventional Registry Trial. Blood. 124(21). 4890–4890. 2 indexed citations
13.
Russo, Roberta, Maria Rosaria Esposito, Antonella Gambale, et al.. (2013). Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II. Blood Cells Molecules and Diseases. 51(1). 17–21. 29 indexed citations
14.
Slone, Jeremy S., Megan Smith, Adam C. Seegmiller, Robert F. Sidonio, & Elizabeth Yang. (2013). Idiopathic Myelofibrosis in Children. Journal of Pediatric Hematology/Oncology. 35(7). 559–565. 6 indexed citations
15.
Kassim, Adetola A., Rosa F. Yeh, Jennifer Domm, et al.. (2013). Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Bone Marrow Transplantation. 49(3). 366–369. 21 indexed citations
16.
Eckrich, Michael J., Winfred C. Wang, Elizabeth Yang, et al.. (2012). Adherence to transcranial Doppler screening guidelines among children with sickle cell disease. Pediatric Blood & Cancer. 60(2). 270–274. 31 indexed citations
17.
Eckrich, Michael J., et al.. (2012). Chronically Transfused Pediatric Sickle Cell Patients are Protected from Cardiac Iron Overload. Pediatric Hematology and Oncology. 29(3). 254–260. 15 indexed citations
18.
Hamid, Rizwan, et al.. (2008). Use of human androgen receptor gene analysis to aid the diagnosis of JMML in female noonan syndrome patients. Pediatric Blood & Cancer. 51(2). 298–302. 3 indexed citations
19.
Marzo, Angelo M. De, Valérie Marchi, Elizabeth Yang, et al.. (1999). Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.. PubMed. 59(16). 3855–60. 145 indexed citations
20.
Friedberg, E C, Janet Chênevert, R. Fleer, et al.. (1986). Molecular Approaches to the Study of Nucleotide Excision Repair in Eukaryotes. PubMed. 38. 311–318. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026